Peripheral Arterial Disease Clinical Trials in Houston, Texas

5 studies are recruiting for peripheral arterial disease in Houston, Texas right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. EVERO Drug-coated Balloon (DCB) Randomized Trial

   The primary objective of the study is to evaluate the long-term safety and effectiveness of the Advance Evero™ 18 Everolimus-coated Percutaneous Transluminal Angioplasty Balloon Catheter (hereafter referred to as the Evero drug-coated balloon [DCB]) in the treatment of the femoropopliteal artery le…

   Stage

   Not phased

   Ages

   18 and older

   Site

   Houston Methodist Hospital, Houston, Texas

   Locations

   10 in total

   Run by

   Cook Research Incorporated

   See if you can join NCT07144150 on ClinicalTrials.gov

2. Efficacy and Safety of Orforglipron in Participants With Peripheral Artery Disease

   The purpose of this study is to evaluate the effect and safety of orforglipron once daily in participants with Fontaine II peripheral arterial disease (PAD). Participation in the study will last about 58 weeks.

   Stage

   Phase 3

   Ages

   18 and older

   Site

   Biopharma Informatic, LLC, Houston, Texas

   Locations

   161 in total

   Run by

   Eli Lilly and Company

   See if you can join NCT07223593 on ClinicalTrials.gov

3. The Golazo® Peripheral Atherectomy System for a Safe and Effective Atherectomy (GREAT Trial)

   The objective of this study is to establish reasonable assurance of safety and effectiveness of the Golazo® Peripheral Atherectomy System when used as indicated in 159 subjects with symptomatic infrainguinal peripheral arterial disease (PAD) in up to 20 investigational sites in the U.S.

   Stage

   Not phased

   Ages

   18 and older

   Site

   Hope Vascular & Podiatry, Houston, Texas

   Locations

   20 in total

   Run by

   Nipro Vascular Innovations Americas, Inc

   See if you can join NCT06321575 on ClinicalTrials.gov

4. SELUTION4BTK Trial

   This study aims to demonstrate superior efficacy and equivalent safety of the SELUTION SLR™ DEB 014 compared to plain (uncoated) balloon angioplasty in the treatment of peripheral arterial disease (PAD) in the BTK arteries in CLTI patients.

   Stage

   Not phased

   Ages

   18 and older

   Site

   Baylor College of Medicine, Houston, Texas

   Locations

   48 in total

   Run by

   M.A. Med Alliance S.A.

   See if you can join NCT05055297 on ClinicalTrials.gov

5. Randomized Clinical Trial for Ewing Amputation in the VA

   This study follows the Pilot Investigation of Ewing Amputation for Veterans with PAD Undergoing a Below Knee Amputation. The 2 year pilot feasibility phase has concluded recruitment and enrollment. The current phase is a 5 year randomized study of Ewing Below Knee Amputation vs. Standard Below Knee…

   Stage

   Not phased

   Ages

   Any age

   Site

   Michael E. DeBakey VA Medical Center, Houston, TX, Houston, Texas

   Locations

   3 in total

   Run by

   VA Office of Research and Development

   See if you can join NCT05437562 on ClinicalTrials.gov